NYSE · Software - Application
DBD (DBD) Stock
$91.55
+2.49%
NYSE: DBD
Technology
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Diebold Nixdorf, Incorporated (DBD) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks · Jul 15, 2026
DBD: Raising target price to $90.00
Argus Research · Jul 15, 2026
Why Diebold Nixdorf, Incorporated (DBD) Outpaced the Stock Market Today
Zacks · Jul 9, 2026
Diebold Nixdorf (DBD) Draws Earnings Focus, Is The Stock Still Undervalued?
Simply Wall St. · Jul 9, 2026
Diebold Nixdorf, Incorporated (DBD) is Attracting Investor Attention: Here is What You Should Know
Zacks · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About DBD
DBD stock trades at $91.55 with a market capitalization of $3.17B. The stock is valued at a price-to-earnings (P/E) ratio of 28.11, price-to-book of 2.25, price-to-sales of 0.67. Over the past 52 weeks the stock has ranged between $51.46 and $91.55, and currently trades at its 52-week high.
On profitability, DBD generates a return on equity (ROE) of 8.64%, return on capital employed of 30.34%, an operating margin of 8.80%, a net profit margin of 2.80%.